

|
BOTANICAL EXTRACTS EPZ LIMITED |


|
Company
Botanical Extracts EPZ Limited (BEEPZ), with four production subsidiaries in East Africa
Location: East Africa
Raw material supply in select areas of Kenya, Uganda and Tanzania Core processing facility in the export processing zone in Athi River, Kenya Satellite processing facility in Kabale, Uganda
BEEPZ is a private limited liability company. Our primary business is the production of artemisinin and artemisinin-derivatives in East Africa to fight drug-resistant malaria. BEEPZ was created to develop a sustainable supply chain for quality artemisinin and artemisinin-derivatives at a price that makes life-saving artemisinin based malaria treatments affordable to the people who need them most. We also aim to provide a return to shareholders that reflects outstanding performance and adequately rewards those who work in our company. BEEPZ has invested more than ten years in the development of artemisinin production in East Africa. Although relatively small, we have developed one of the strongest technical bases for the production of artemisinin outside of the traditional producers in China and Vietnam. We produce artemisinin for the only pharmaceutical company currently able to supply life-saving artemisinin-based malaria treatments to the WHO and Global Fund. We are proud to stay that the bulk of our production goes to provision of artemisinin-based malaria treatments sold at cost to the poor in malaria endemic countries (mostly in Africa).
BEEPZ is the only significant producer of artemisinin on the African continent:
148 full-time staff are currently employed BEEPZ produced artemisinin for manufacture of over 8 Million artemisinin-based malaria treatments in 2009 BEEPZ has contracted over 1,200 farmers, primarily smallholders, for raw material production
Through direct investment in Africa, BEEPZ is making a significant contribution to the provision of effective, low-cost malaria treatments where they are needed most.
To learn more about BEEPZ, please contact us. |
|
Media Centre |